Winthrop-University Hospital's new Interventional Cardiology Pavilion has a name, thanks to a $1,000,000 gift from Garden City resident John D. Miller.
The Miller Interventional Cardiology Pavilion, which is scheduled to open in 2004, will better accommodate the increasing number of patients seeking help from Winthrop's interventional cardiologists.
Donor John Miller (left) stands in the first of three new Electrophysiology Laboratories to open in Winthrop's new Miller Interventional Cardiology Pavilion with Kevin Marzo, MD, Chief, Division of Cardiology (center) and Todd Cohen, MD, Director of Electrophysiology/ Director of Winthrop's Pacemaker-Arrhythmia Center (right).
"We are very grateful for Mr. Miller's support and commitment to our Hospital," said Daniel P. Walsh, President and CEO of Winthrop. "This is an extraordinary gift that will positively affect the lives of so many people in the region."
"It is truly an honor and a privilege for me to be so involved with the Hospital and to support this very special project," said John D. Miller. "After all, I was born at Winthrop, grew up in the area, and now call Garden City home. It's quite a hospital, and I can only hope my contribution motivates others in the community to help Winthrop complete the many capital improvements that will benefit all of us."
A member of the Winthrop-University Hospital Board of Directors, Mr. Miller was a founder of Arterial Vascular Engineering, Inc. (AVE) and served as Chief Financial Officer, Treasurer and a Director. AVE began as a start-up medical device company in 1991, and went on to become a leading cardiology company with over 4,400 employees worldwide. AVE went public in 1996, and was acquired by Medtronic Corp. in 1999.
The Miller Interventional Cardiology Pavilion
The new Pavilion will include a technologically-upgraded Cardiac Catheterization Center to enable Winthrop's cardiologists to better assist patients who need their coronary vessels examined and cleared with greater precision. A fourth computerized cardiac catheterization laboratory will be constructed, the existing three labs will be upgraded, and a new expanded recovery unit will be built with a new family waiting area. The latest generation all-digital cardiovascular imaging system will also be installed.
The cardiac catheterization team - which can be mobilized in minutes, 24 hours a day - is renowned for excellence in evaluating the extent of heart damage and offering relief through non-surgical methods such as implantation of the latest medication-coated stents that work to keep vessels free of obstructive plaque.
In fact, a team of interventional cardiologists at Winthrop was one of the first on Long Island to utilize the new FDA approved drug-releasing stents to keep arteries open following angioplasty procedures.
First of Three
EP Labs Opened
Winthrop's newly expanded Electrophysiology Center will also be housed in the Pavilion. The first of three electrophysiology laboratories was recently opened, featuring the most advanced technology for diagnosing and treating arrhythmias.
The new facility will enable the Hospital to meet the increasing demand for services and accommodate more patients for diagnosis and procedures that will help improve lives. With the first phase of the comprehensive expansion project complete, focus will turn to the construction of the additional EP labs as well as a modernized tilt table room-the 'gold standard' for evaluating the sudden loss of consciousness.
The Center will also have a 17-bed recovery area with a dedicated nurse's station and a comfortable family lounge.
For more information on making a donation to Winthrop-University Hospital's Capital Campaign, contact the Office of Development at (516) 663-3398.